Compare $CLPT vs $ELMD | Chartloom

Compare

$CLPT vs $ELMD

Clearpoint Neuro Inc · Electromed Inc

CLPT

Clearpoint Neuro Inc

ELMD

Electromed Inc

Compare $CLPT vs $ELMD

Comparing Clearpoint Neuro Inc and Electromed Inc

CLPTClearpoint Neuro Inc

ELMDElectromed Inc

CLPTClearpoint Neuro Inc

Market cap

$314M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.82x

Rev growth (TTM)

25.9%

YTD performance

-25.3%

52W performance

-64.6%

FCF yield

-10.0%

ELMDElectromed Inc

Market cap

$229M

P/E (TTM)

21.40x

Forward P/E (NTM)

18.72x

Forward P/S (NTM)

2.70x

Rev growth (TTM)

15.3%

YTD performance

1.1%

52W performance

10.2%

FCF yield

3.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLPT

ELMD

Detailed metrics comparison

CLPT

Clearpoint Neuro Inc

ELMD

Electromed Inc

Market Cap

CLPT$314M

ELMD$229M

Enterprise Value

CLPT$335M

ELMD$209M

Price

CLPT$10.48

ELMD$27.69

P/E Ratio

CLPTN/A

ELMD21.40x

P/S Ratio

CLPT7.43x

ELMD3.11x

EV/Sales

CLPT7.93x

ELMD2.83x

EV/EBITDA

CLPT0.00x

ELMD13.96x

P/B Ratio

CLPT30.84x

ELMD4.31x

P/FCF Ratio

CLPTN/A

ELMD27.41x

EV/FCF

CLPT-10.71x

ELMD24.96x

PEG Ratio

CLPTN/A

ELMD0.41x

Forward P/E (NTM)

CLPTN/A

ELMD18.72x

Forward P/S (NTM)

CLPT5.82x

ELMD2.70x

Revenue (TTM)

CLPT$42M

ELMD$74M

Revenue Growth (YoY)

CLPT25.9%

ELMD15.3%

Forward Rev Growth

CLPT15.4%

ELMD10.7%

Gross Margin (TTM)

CLPT62.6%

ELMD78.5%

Operating Margin (TTM)

CLPT0.0%

ELMD18.8%

EBITDA Margin (TTM)

CLPT-69.3%

ELMD20.3%

Net Margin (TTM)

CLPT-81.8%

ELMD15.3%

FCF Margin (TTM)

CLPT-74.0%

ELMD11.3%

Net Income (TTM)

CLPT$-35M

ELMD$11M

FCF (TTM)

CLPT$-31M

ELMD$8M

EPS (TTM)

CLPT-$1.15

ELMD$1.29

ROE (TTM)

CLPT-18809.0%

ELMD23.4%

ROA (TTM)

CLPT-4087.0%

ELMD19.3%

ROIC (TTM)

CLPT-5494.0%

ELMD23.4%

Cash

CLPT$29M

ELMD$20M

Debt

CLPT$50M

ELMD$0

Net Cash/Debt

CLPT$-21M

ELMD$20M

Current Ratio (TTM)

CLPT4.74x

ELMD4.69x

Quick Ratio (TTM)

CLPT3.75x

ELMD4.30x

Debt/Equity (TTM)

CLPT4.66x

ELMD0.00x

Debt/Assets (TTM)

CLPT0.0%

ELMD0.0%

Interest Coverage (TTM)

CLPTN/A

ELMDN/A

Net Debt/EBITDA (TTM)

CLPT0.00x

ELMD0.00x

Beta

CLPT1.31

ELMD0.43

52W Performance

CLPT-64.6%

ELMD10.2%

YTD Performance

CLPT-25.3%

ELMD1.1%

% from 52W High

CLPT-65.2%

ELMD-41.6%

% from 52W Low

CLPT26.7%

ELMD20.3%

Asset Turnover (TTM)

CLPT0.50x

ELMD1.26x

FCF Yield (TTM)

CLPT-10.0%

ELMD3.6%

Earnings Yield (TTM)

CLPT-11.0%

ELMD4.9%

Dividend Yield (TTM)

CLPTN/A

ELMDN/A

Rule of 40

CLPT-48.2

ELMD26.6

EV/GP/RG

CLPT0.46

ELMD0.24

Ticker research

View CLPT research View ELMD research

Metric	CLPT Clearpoint Neuro Inc	ELMD Electromed Inc
Market & Valuation
Market Cap	$314M	$229M
Enterprise Value	$335M	$209M
Price	$10.48	$27.69
P/E Ratio	N/A	21.40x
P/S Ratio	7.43x	3.11x
EV/Sales	7.93x	2.83x
EV/EBITDA	0.00x	13.96x
P/B Ratio	30.84x	4.31x
P/FCF Ratio	N/A	27.41x
EV/FCF	-10.71x	24.96x
PEG Ratio	N/A	0.41x
Forward P/E (NTM)	N/A	18.72x
Forward P/S (NTM)	5.82x	2.70x
Revenue & Growth
Revenue (TTM)	$42M	$74M
Revenue Growth (YoY)	25.9%	15.3%
Forward Rev Growth	15.4%	10.7%
Profitability
Gross Margin (TTM)	62.6%	78.5%
Operating Margin (TTM)	0.0%	18.8%
EBITDA Margin (TTM)	-69.3%	20.3%
Net Margin (TTM)	-81.8%	15.3%
FCF Margin (TTM)	-74.0%	11.3%
Net Income (TTM)	$-35M	$11M
FCF (TTM)	$-31M	$8M
EPS (TTM)	-$1.15	$1.29
ROE (TTM)	-18809.0%	23.4%
ROA (TTM)	-4087.0%	19.3%
ROIC (TTM)	-5494.0%	23.4%
Financial Health
Cash	$29M	$20M
Debt	$50M	$0
Net Cash/Debt	$-21M	$20M
Current Ratio (TTM)	4.74x	4.69x
Quick Ratio (TTM)	3.75x	4.30x
Debt/Equity (TTM)	4.66x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.31	0.43
52W Performance	-64.6%	10.2%
YTD Performance	-25.3%	1.1%
% from 52W High	-65.2%	-41.6%
% from 52W Low	26.7%	20.3%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	1.26x
FCF Yield (TTM)	-10.0%	3.6%
Earnings Yield (TTM)	-11.0%	4.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-48.2	26.6
EV/GP/RG	0.46	0.24
Ticker research	View CLPT research	View ELMD research

Valuation

P/E Ratio

ELMD

21.40x

P/S Ratio

ELMD

3.11x

CLPT

7.43x

EV/FCF

CLPT

-10.71x

ELMD

24.96x

Growth & revenue

Revenue Growth TTM

CLPT

25.9%

ELMD

15.3%

Forward Revenue Growth

CLPT

15.4%

ELMD

10.7%

Profitability & performance

Gross Margin

ELMD

78.5%

CLPT

62.6%

ROE

ELMD

23.4%

CLPT

-18809.0%

FCF Yield %

ELMD

3.6%

CLPT

-10.0%

52-Week Performance

ELMD

10.2%

CLPT

-64.6%

Detailed metrics comparison

CLPT

Clearpoint Neuro Inc

ELMD

Electromed Inc

Market Cap

CLPT$314M

ELMD$229M

Enterprise Value

CLPT$335M

ELMD$209M

Price

CLPT$10.48

ELMD$27.69

P/E Ratio

CLPTN/A

ELMD21.40x

P/S Ratio

CLPT7.43x

ELMD3.11x

EV/Sales

CLPT7.93x

ELMD2.83x

EV/EBITDA

CLPT0.00x

ELMD13.96x

P/B Ratio

CLPT30.84x

ELMD4.31x

P/FCF Ratio

CLPTN/A

ELMD27.41x

EV/FCF

CLPT-10.71x

ELMD24.96x

PEG Ratio

CLPTN/A

ELMD0.41x

Forward P/E (NTM)

CLPTN/A

ELMD18.72x

Forward P/S (NTM)

CLPT5.82x

ELMD2.70x

Revenue (TTM)

CLPT$42M

ELMD$74M

Revenue Growth (YoY)

CLPT25.9%

ELMD15.3%

Forward Rev Growth

CLPT15.4%

ELMD10.7%

Gross Margin (TTM)

CLPT62.6%

ELMD78.5%

Operating Margin (TTM)

CLPT0.0%

ELMD18.8%

EBITDA Margin (TTM)

CLPT-69.3%

ELMD20.3%

Net Margin (TTM)

CLPT-81.8%

ELMD15.3%

FCF Margin (TTM)

CLPT-74.0%

ELMD11.3%

Net Income (TTM)

CLPT$-35M

ELMD$11M

FCF (TTM)

CLPT$-31M

ELMD$8M

EPS (TTM)

CLPT-$1.15

ELMD$1.29

ROE (TTM)

CLPT-18809.0%

ELMD23.4%

ROA (TTM)

CLPT-4087.0%

ELMD19.3%

ROIC (TTM)

CLPT-5494.0%

ELMD23.4%

Cash

CLPT$29M

ELMD$20M

Debt

CLPT$50M

ELMD$0

Net Cash/Debt

CLPT$-21M

ELMD$20M

Current Ratio (TTM)

CLPT4.74x

ELMD4.69x

Quick Ratio (TTM)

CLPT3.75x

ELMD4.30x

Debt/Equity (TTM)

CLPT4.66x

ELMD0.00x

Debt/Assets (TTM)

CLPT0.0%

ELMD0.0%

Interest Coverage (TTM)

CLPTN/A

ELMDN/A

Net Debt/EBITDA (TTM)

CLPT0.00x

ELMD0.00x

Beta

CLPT1.31

ELMD0.43

52W Performance

CLPT-64.6%

ELMD10.2%

YTD Performance

CLPT-25.3%

ELMD1.1%

% from 52W High

CLPT-65.2%

ELMD-41.6%

% from 52W Low

CLPT26.7%

ELMD20.3%

Asset Turnover (TTM)

CLPT0.50x

ELMD1.26x

FCF Yield (TTM)

CLPT-10.0%

ELMD3.6%

Earnings Yield (TTM)

CLPT-11.0%

ELMD4.9%

Dividend Yield (TTM)

CLPTN/A

ELMDN/A

Rule of 40

CLPT-48.2

ELMD26.6

EV/GP/RG

CLPT0.46

ELMD0.24

Ticker research

View CLPT research View ELMD research

Metric	CLPT Clearpoint Neuro Inc	ELMD Electromed Inc
Market & Valuation
Market Cap	$314M	$229M
Enterprise Value	$335M	$209M
Price	$10.48	$27.69
P/E Ratio	N/A	21.40x
P/S Ratio	7.43x	3.11x
EV/Sales	7.93x	2.83x
EV/EBITDA	0.00x	13.96x
P/B Ratio	30.84x	4.31x
P/FCF Ratio	N/A	27.41x
EV/FCF	-10.71x	24.96x
PEG Ratio	N/A	0.41x
Forward P/E (NTM)	N/A	18.72x
Forward P/S (NTM)	5.82x	2.70x
Revenue & Growth
Revenue (TTM)	$42M	$74M
Revenue Growth (YoY)	25.9%	15.3%
Forward Rev Growth	15.4%	10.7%
Profitability
Gross Margin (TTM)	62.6%	78.5%
Operating Margin (TTM)	0.0%	18.8%
EBITDA Margin (TTM)	-69.3%	20.3%
Net Margin (TTM)	-81.8%	15.3%
FCF Margin (TTM)	-74.0%	11.3%
Net Income (TTM)	$-35M	$11M
FCF (TTM)	$-31M	$8M
EPS (TTM)	-$1.15	$1.29
ROE (TTM)	-18809.0%	23.4%
ROA (TTM)	-4087.0%	19.3%
ROIC (TTM)	-5494.0%	23.4%
Financial Health
Cash	$29M	$20M
Debt	$50M	$0
Net Cash/Debt	$-21M	$20M
Current Ratio (TTM)	4.74x	4.69x
Quick Ratio (TTM)	3.75x	4.30x
Debt/Equity (TTM)	4.66x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.31	0.43
52W Performance	-64.6%	10.2%
YTD Performance	-25.3%	1.1%
% from 52W High	-65.2%	-41.6%
% from 52W Low	26.7%	20.3%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	1.26x
FCF Yield (TTM)	-10.0%	3.6%
Earnings Yield (TTM)	-11.0%	4.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-48.2	26.6
EV/GP/RG	0.46	0.24
Ticker research	View CLPT research	View ELMD research